SITC Guidelines Provide a Fresh Look at Evolving Strategies for Melanoma

March 14, 2019 – New therapeutic approaches for treating patients with earlier-stage melanoma who face a higher risk of recurrence are among the features of recently updated consensus guidelines from the Society for Immunotherapy of Cancer (SITC). The guidelines take stock of the extensive changes that have occurred in the field in less than a decade, with the goal of helping to stratify patients, choose optimal treatment regimens, and manage adverse … (leggi tutto)